Trailing Dividend / Share
$0.00
Roivant Sciences Ltd. (ROIV) Dividend History
Income profile from 2019 to 2024 with payout safety and yield-on-cost trend
Dividend Yield
N/A
Payout Ratio
N/A
Unknown
Dividend Streak
1 years
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
1 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9
Growth
Growth Streak1 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield100.0%
Total Shareholder Yield100.0%
1Y Total Return169.5%
5Y Total Return184.6%
Estimated $10K growth (return + dividends):
5Y ago$28,45610Y ago$27,82720Y ago$27,827
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). ROIV's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.
Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Dividend Analysis
Payout Safety
Roivant Sciences Ltd. has limited earnings payout data (Unknown).
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
ROIV has raised its dividend for 1 consecutive year.
Total Shareholder Returns
Beyond cash dividends, ROIV returns capital through share repurchases. The combined picture: 100.0% buyback yield, 100.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 184.6%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $27,827 today.
Dividend Peer Comparison
Peer group: Drug Discovery and Antibody Platforms
Div Yield
—
—
Safety
Unknown
— payout
Streak
1Y
— 5Y CAGR
Total Shareholder
100.0%
#1 of 3
Annual Dividend History
6 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | — | 0 | $-0.24 | — | — | — |
| 2023 | $0.00 | — | 0 | $5.23 | — | — | — |
| 2022 | $0.00 | — | 0 | $-1.42 | — | — | — |
| 2021 | $0.00 | — | 0 | $-1.26 | — | — | — |
| 2020 | $0.00 | — | 0 | $-1.18 | — | — | — |
| 2019 | $0.00 | — | 0 | $1.75 | — | — | — |
See ROIV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ROIV Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ROIV vs AGIO
See how ROIV stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does ROIV pay per share?
Roivant Sciences Ltd. (ROIV) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is ROIV's next ex-dividend date?
ROIV's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. ROIV typically pays dividends quarterly.
Is ROIV's dividend safe?
ROIV's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The 1-year growth streak provides moderate confidence.
How many years has ROIV increased its dividend?
ROIV has 1 consecutive years of dividend growth. The 5-year dividend CAGR is N/A.
How often does ROIV pay dividends?
Roivant Sciences Ltd. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 5+ years from 2019 to 2024.
How much would $10,000 invested in ROIV grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in ROIV five years ago would be worth approximately $28,456 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is ROIV's yield on cost for long-term holders?
ROIV's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.